Canada markets close in 4 hours 48 minutes
  • S&P/TSX

    20,079.22
    -64.82 (-0.32%)
     
  • S&P 500

    4,176.80
    -45.06 (-1.07%)
     
  • DOW

    33,347.08
    -476.37 (-1.41%)
     
  • CAD/USD

    0.8027
    -0.0067 (-0.83%)
     
  • CRUDE OIL

    71.87
    +0.83 (+1.17%)
     
  • BTC-CAD

    45,727.72
    -2,964.18 (-6.09%)
     
  • CMC Crypto 200

    907.56
    -32.39 (-3.45%)
     
  • GOLD FUTURES

    1,778.20
    +3.40 (+0.19%)
     
  • RUSSELL 2000

    2,253.04
    -34.42 (-1.50%)
     
  • 10-Yr Bond

    1.4770
    -0.0340 (-2.25%)
     
  • NASDAQ

    14,050.34
    -111.01 (-0.78%)
     
  • VOLATILITY

    19.75
    +2.00 (+11.27%)
     
  • FTSE

    7,027.11
    -126.32 (-1.77%)
     
  • NIKKEI 225

    28,964.08
    -54.25 (-0.19%)
     
  • CAD/EUR

    0.6768
    -0.0026 (-0.38%)
     

Xenetic Biosciences: Q1 Earnings Snapshot

·1 min read

FRAMINGHAM, Mass. (AP) _ Xenetic Biosciences, Inc. (XBIO) on Wednesday reported a loss of $1.3 million in its first quarter.

The Framingham, Massachusetts-based company said it had a loss of 15 cents per share.

The company posted revenue of $191,200 in the period. Its adjusted revenue was $191,000.

The company's shares closed at $1.79. A year ago, they were trading at 90 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XBIO at https://www.zacks.com/ap/XBIO

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting